172 related articles for article (PubMed ID: 23845253)
1. Bayesian approach for clinical trial safety data using an Ising prior.
McEvoy BW; Nandy RR; Tiwari RC
Biometrics; 2013 Sep; 69(3):661-72. PubMed ID: 23845253
[TBL] [Abstract][Full Text] [Related]
2. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
Xia HA; Ma H; Carlin BP
J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian group sequential approach to safety signal detection.
Chen W; Zhao N; Qin G; Chen J
J Biopharm Stat; 2013; 23(1):213-30. PubMed ID: 23331232
[TBL] [Abstract][Full Text] [Related]
4. Detecting potential safety issues in clinical trials by Bayesian screening.
Gould AL
Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
[TBL] [Abstract][Full Text] [Related]
5. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
Huang L; Zalkikar J; Tiwari RC
J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
[TBL] [Abstract][Full Text] [Related]
6. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
Ahmed I; Haramburu F; Fourrier-Réglat A; Thiessard F; Kreft-Jais C; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
Stat Med; 2009 Jun; 28(13):1774-92. PubMed ID: 19360795
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of drug safety information using large-scale adverse drug reactions database].
Morikawa K
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
[TBL] [Abstract][Full Text] [Related]
8. Detecting potential safety issues in large clinical or observational trials by Bayesian screening when event counts arise from poisson distributions.
Gould AL
J Biopharm Stat; 2013; 23(4):829-47. PubMed ID: 23786257
[TBL] [Abstract][Full Text] [Related]
9. Application of the Bayesian dynamic survival model in medicine.
He J; McGee DL; Niu X
Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
[TBL] [Abstract][Full Text] [Related]
10. Large hierarchical Bayesian analysis of multivariate survival data.
Gustafson P
Biometrics; 1997 Mar; 53(1):230-42. PubMed ID: 9147593
[TBL] [Abstract][Full Text] [Related]
11. Bayesian hierarchical modeling of drug stability data.
Chen J; Zhong J; Nie L
Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
[TBL] [Abstract][Full Text] [Related]
12. Bayesian semiparametric intensity estimation for inhomogeneous spatial point processes.
Yue YR; Loh JM
Biometrics; 2011 Sep; 67(3):937-46. PubMed ID: 21175553
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Odani M; Fukimbara S; Sato T
Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
[TBL] [Abstract][Full Text] [Related]
14. Flexible Bayesian quantile regression for independent and clustered data.
Reich BJ; Bondell HD; Wang HJ
Biostatistics; 2010 Apr; 11(2):337-52. PubMed ID: 19948746
[TBL] [Abstract][Full Text] [Related]
15. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
16. Mining pharmacovigilance data using Bayesian logistic regression with James-Stein type shrinkage estimation.
An L; Fung KY; Krewski D
J Biopharm Stat; 2010 Sep; 20(5):998-1012. PubMed ID: 20721787
[TBL] [Abstract][Full Text] [Related]
17. Signal detection in FDA AERS database using Dirichlet process.
Hu N; Huang L; Tiwari RC
Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
[TBL] [Abstract][Full Text] [Related]
18. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
Jordan P; Brunschwig H; Luedin E
Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
[TBL] [Abstract][Full Text] [Related]
19. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.
Berlin C; Blanch C; Lewis DJ; Maladorno DD; Michel C; Petrin M; Sarp S; Close P
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):622-30. PubMed ID: 21994119
[TBL] [Abstract][Full Text] [Related]
20. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence.
Xiao C; Li Y; Baytas IM; Zhou J; Wang F
Sci Rep; 2018 Jan; 8(1):1806. PubMed ID: 29379048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
